MIM
TMO icon

Meridiem Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Meridiem Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$216M Sell
438,260
-14,738
-3% -$8M 5.5% 8
2025
Q4 		$263M Sell
452,998
-22,610
-5% -$12.8M 5.54% 7
2025
Q3 		$231M Sell
475,608
-189,285
-28% -$88.1M 4.41% 12
2025
Q2 		$270M Buy
664,893
+3,675
+0.6% +$1.54M 4.9% 12
2025
Q1 		$329M Buy
661,218
+29,362
+5% +$15.9M 6.02% 4
2024
Q4 		$329M Buy
631,856
+79,555
+14% +$43.7M 5.88% 3
2024
Q3 		$341M Sell
552,301
-5,832
-1% -$3.45M 6.07% 3
2024
Q2 		$308M Sell
558,133
-16,615
-3% -$9.52M 5.79% 6
2024
Q1 		$334M Buy
574,748
+11,556
+2% +$6.48M 6.55% 1
2023
Q4 		$299M Buy
563,192
+153,674
+38% +$74.4M 6.45% 1
2023
Q3 		$207M Buy
409,518
+358
+0.1% +$191K 5.55% 4
2023
Q2 		$213M Buy
409,160
+1,548
+0.4% +$835K 5.5% 6
2023
Q1 		$235M Buy
407,612
+2,627
+0.6% +$1.48M 6.6% 1
2022
Q4 		$223M Buy
404,985
+5,836
+1% +$3.09M 6.92% 2
2022
Q3 		$203M Sell
399,149
-84,444
-17% -$47.3M 6.86% 2
2022
Q2 		$263M Buy
483,593
+55,992
+13% +$30.8M 7.24% 2
2022
Q1 		$253M Buy
427,601
+70,384
+20% +$40.4M 7.15% 2
2021
Q4 		$238M Sell
357,217
-22,548
-6% -$14.1M 7.19% 2
2021
Q3 		$217M Buy
379,765
+3,046
+0.8% +$1.67M 7.34% 1
2021
Q2 		$190M Buy
376,719
+23,281
+7% +$11M 6.9% 4
2021
Q1 		$161M Buy
353,438
+16,634
+5% +$7.94M 6.49% 4
2020
Q4 		$157M Buy
+336,804
New +$158M 8.2% 3

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meridiem Investment Management's TMO Position: Q1 2026 in Review

Meridiem Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 3.3% in Q1 2026, selling an estimated $8M and leaving 438,260 shares worth $216M. The position accounts for 5.5% of the portfolio, ranked #8.

Meridiem Investment Management first reported a position in TMO in Q4 2020 and has held it in 22 quarters since. The position peaked at $341M in Q3 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Meridiem Investment Management held 438,260 shares of Thermo Fisher Scientific worth $216M as of Q1 2026.
  • Meridiem Investment Management sold 14,738 Thermo Fisher Scientific shares in Q1 2026, an estimated $8M.
  • Thermo Fisher Scientific made up 5.5% of Meridiem Investment Management's portfolio in Q1 2026, its #8 holding.
  • Meridiem Investment Management first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 22 quarters since.
  • Meridiem Investment Management's Thermo Fisher Scientific position peaked at $341M in Q3 2024.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Meridiem Investment Management's 13F filing for Q1 2026, filed 12 May 2026.